Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study

Academic Article
Publication Date:
2018
abstract:
Background and purposeThe purpose of this study was to determine whether switching from branded levetiracetam (Keppra((R))) to a levetiracetam generic equivalent product (Matever((R))) in an epilepsy cohort could provide adequate results in terms of seizure control and tolerability.
Iris type:
01.01 Articolo in rivista
Keywords:
antiepileptic drug equivalent; focal epilepsy; generalized epilepsy; Keppra((R)); levetiracetam; Matever((R))
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/343223
Published in:
EUROPEAN JOURNAL OF NEUROLOGY (PRINT)
Journal